Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGEN | ITCI | BPMC | ||
| Company | Repligen Corp | Intra-Cellular Ther | Blueprint Medicines Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 123.30 | 68.77 | 108.93 | ||
| High | 124.91 | 69.37 | 110.46 | ||
| Low | 120.05 | 68.15 | 107.46 | ||
| Last | 120.14 | 68.54 | 110.36 | ||
| Change | -3.18 | +0.55 | +1.18 | ||
| % Change | -2.58% | +0.81% | +1.08% | ||
| Volume | 538,700 | 1,396,900 | 487,000 | ||
| 20-Day Average Volume | 941,600 | 1,763,750 | 616,065 | ||
| Previous Close | 123.32 | 67.99 | 109.18 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 131.58 | 70.34 | 105.77 | ||
| 20-Day Raw Stochastic | 16.39% | 18.58% | 90.15% | ||
| 20-Day Relative Strength | 29.42% | 47.65% | 60.04% | ||
| Weighted Alpha | -31.37 | +11.24 | +97.09 | ||
| Today's Opinion | 88% Sell | 48% Buy | 100% Buy | ||
| Previous Opinion | 88% Sell | 40% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Sell | 24% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.44% since 06/25/24 | -5.36% since 06/25/24 | +3.58% since 06/25/24 | ||
| Low | 120.05 on 07/02/24 | 66.26 on 07/01/24 | 103.01 on 06/27/24 | ||
| High | 129.23 on 06/26/24 | 72.36 on 06/26/24 | 111.42 on 06/28/24 | ||
| 1-Month | |||||
| %Chg | -19.42% since 05/31/24 | +1.93% since 05/31/24 | +4.55% since 05/31/24 | ||
| Low | 113.50 on 06/20/24 | 66.26 on 07/01/24 | 100.67 on 06/10/24 | ||
| High | 154.02 on 06/06/24 | 78.53 on 06/18/24 | 111.42 on 06/28/24 | ||
| 3-Month | |||||
| %Chg | -32.48% since 04/02/24 | +2.80% since 04/02/24 | +20.53% since 04/02/24 | ||
| Low | 113.50 on 06/20/24 | 64.09 on 05/20/24 | 84.33 on 04/15/24 | ||
| High | 182.21 on 04/09/24 | 84.89 on 04/16/24 | 111.42 on 06/28/24 | ||
| 6-Month | |||||
| %Chg | -32.99% since 01/02/24 | -2.77% since 01/02/24 | +21.18% since 01/02/24 | ||
| Low | 113.50 on 06/20/24 | 62.78 on 02/22/24 | 72.24 on 02/14/24 | ||
| High | 211.13 on 02/16/24 | 84.89 on 04/16/24 | 111.42 on 06/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,890,628 | 7,178,043 | 6,836,525 | ||
| Shares Outstanding, K | 55,876 | 105,575 | 62,617 | ||
| Annual Sales | 638,760,000 | 464,370,000 | 249,380,000 | ||
| Annual Net Income | 41,580,000 | -139,670,000 | -506,980,000 | ||
| Last Quarter Sales | 151,350,000 | 144,870,000 | 96,120,000 | ||
| Last Quarter Net Income | 2,090,000 | -15,250,000 | 89,140,000 | ||
| 60-Month Beta | 0.96 | 1.01 | 0.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.28 on 05/01/24 | -0.16 on 05/07/24 | -1.32 on 05/02/24 | ||
| Latest Earnings Date | 08/07/24 | 08/01/24 | 08/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 92.01 | 0.00 | 0.00 | ||